CoChat

Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease

Open access

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index; none of the 76 sources its claims cite is checked for support yet.

Abstract

Alzheimer's disease (AD) is characterized by amyloid plaques composed of the β-amyloid (Aβ) peptide surrounded by swollen presynaptic dystrophic neurites consisting of dysfunctional axons and terminals that accumulate the β-site amyloid precursor protein (APP) cleaving enzyme (BACE1) required for Aβ generation. The cellular and molecular mechanisms that govern presynaptic dystrophic neurite formation are unclear, and elucidating these processes may lead to novel AD therapeutic strategies. Previous studies suggest Aβ may disrupt microtubules, which we hypothesize have a critical role in the development of presynaptic dystrophies. To investigate this further, here we have assessed the effects of Aβ, particularly neurotoxic Aβ42, on microtubules during the formation of presynaptic dystrophic neurites in vitro and in vivo. Live-cell imaging of primary neurons revealed that exposure to Aβ42 oligomers caused varicose and beaded neurites with extensive microtubule disruption, and inhibited anterograde and retrograde trafficking. In brain sections from AD patients and the 5XFAD transgenic mouse model of amyloid pathology, dystrophic neurite halos with BACE1 elevation around amyloid plaques exhibited aberrant tubulin accumulations or voids. At the ultrastructural level, peri-plaque dystrophies were strikingly devoid of microtubules and replete with multi-lamellar vesicles resembling autophagic intermediates. Proteins of the microtubule motors, kinesin and dynein, and other neuronal proteins were aberrantly localized in peri-plaque dystrophies. Inactive pro-cathepsin D also accumulated in peri-plaque dystrophies, indicating reduced lysosomal function. Most importantly, BACE1 accumulation in peri-plaque dystrophies caused increased BACE1 cleavage of APP and Aβ generation. Our study supports the hypothesis that Aβ induces microtubule disruption in presynaptic dystrophic neurites that surround plaques, thus impairing axonal transport and leading to accumulation of BACE1 and exacerbation of amyloid pathology in AD.

Overview

CoChat Summary

TL;DR

This study shows that Aβ42 oligomers disrupt microtubules and cause neuritic beading in primary neurons, and that BACE1-positive peri-plaque dystrophic neurites in AD and 5XFAD mice lack intact microtubules, mislocalize motor proteins, and accumulate BACE1-cleaved APP products including Aβ42. The authors propose a feed-forward mechanism in which local Aβ toxicity impairs axonal transport, causing BACE1/APP accumulation and increased Aβ generation around plaques.

Key findings

  • In primary cortical neurons, 1 μM Aβ42 oligomers for 72 h caused βIII-tubulin accumulations and neuritic beading; live imaging with 10 μM Aβ42 showed microtubule disruption and beading as early as 3.5 h, with a small but significant decrease in Tubulin Tracker fluorescence ratio versus vehicle (p = 0.004) and no increase in propidium iodide-labeled dead cells at 3.5 h.
  • In post-mortem AD superior temporal gyrus (3 AD, 3 controls) and 5XFAD mouse brain, BACE1-positive peri-plaque dystrophies showed reduced βIII-tubulin, acetylated α-tubulin, and polyglutamylated tubulin immunostaining, with significantly elevated BACE1/tubulin intensity ratios versus normal neuropil (p < 0.001).
  • By EM, peri-plaque dystrophic axons in 5XFAD mice were filled with multilamellar vesicles and were strikingly devoid of intact microtubules; dynein intermediate chain and p150glued were reduced in dystrophies, while dynamitin and kinesin heavy chain accumulated.
  • 5XFAD cortex had nearly twofold higher immature pro-cathepsin D than non-transgenic cortex, while mature cathepsin D heavy chain was not significantly changed; peri-plaque dystrophies also showed increased sAPPβ, 3D6/Aβ, and Aβ42 neoepitope immunoreactivity co-localizing with BACE1, indicating increased BACE1 cleavage of APP and Aβ generation.

Methods

  • Primary mouse cortical neurons (E15.5–16.5 C57BL/6) were treated with Aβ42 oligomers or vehicle and analyzed by immunofluorescence, live-cell Tubulin Tracker imaging, propidium iodide labeling, and kymograph analysis of BACE1-YFP and NPY-mCherry trafficking.
  • Human post-mortem superior temporal gyrus from three AD patients and three cognitively normal controls was immunostained for BACE1, tubulin isoforms, and methoxy XO4; at least 10 plaques per case were imaged.
  • 5XFAD and 5XFAD;BACE1−/− mice were analyzed by immunofluorescence, electron microscopy, and immunoblotting; for proteins not previously published, 5–8 male and female 5XFAD mice at 5–6 or 9 months were used, with 20–40 plaques imaged per antibody stain.

Limitations

  • The paper states that post-mortem AD brain represents end-stage disease and provides limited information about pathogenesis; it also states that it cannot formally exclude APP processing elsewhere followed by product trafficking to dystrophies, and cannot exclude that some BACE1-positive dystrophies are post-synaptic/dendritic.
  • The paper notes that the in vitro Aβ42 oligomer concentrations (1–10 μM) were used to model high local peri-plaque concentrations, that absolute soluble Aβ concentrations immediately around plaques were not quantified, and that the relationship between in vitro and in vivo results requires further investigation.
  • Evident from the text: human tissue analysis used a small sample (three AD and three control cases), and much of the mechanistic evidence is correlative across a transgenic mouse model and cultured neurons rather than direct causal testing in human brain.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00401-016-1558-9

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Oligomeric Aβ42 causes neurite beading and microtubule disruption in primary neurons. a Primary cortical neurons were cultured from e15.5 mouse embryos and after 9 days in vitro were exposed to 1 μM Aβ42 oligomers or vehicle. After 72 h, coverslips were fixed in 4 % paraformaldehyde, permeabilized, and stained with the antibody TuJ1 against βIII-tubulin (red) and DAPI (blue). Neurite beading is very prominent in Aβ42-treated cultures, while neurites appear smooth and unbeaded in vehicle-treated neurons. b Primary neurons were isolated as described in a, and after 12 days in vitro were exposed to 10 μM Aβ42 oligomers or vehicle. After 22 h of Aβ42 treatment, the fluorescent microtubule probe Tubulin Tracker was added to a final concentration of 250 nM for 30 min. Unfixed, live neurons were then imaged at ×20 using a Nikon Eclipse TS100 microscope with NIS Elements software. Note that Aβ42-induced neurite beading visualized by Tubulin Tracker appears very similar to that observed with βIII-tubulin immunostaining in a, and occurs more rapidly with higher Aβ42 concentration. Taken together, these results strongly suggest that Aβ42 disrupts the organization of microtubules in neurons. Scale bars in all frames 50 μm
Fig. 1 Oligomeric Aβ42 causes neurite beading and microtubule disruption in primary neurons. a Primary cortical neurons were cultured from e15.5 mouse embryos and after 9 days in vitro were exposed to 1 μM Aβ42 oligomers or vehicle. After 72 h, coverslips were fixed in 4 % paraformaldehyde, permeabilized, and stained with the antibody TuJ1 against βIII-tubulin (red) and DAPI (blue). Neurite beading is very prominent in Aβ42-treated cultures, while neurites appear smooth and unbeaded in vehicle-treated neurons. b Primary neurons were isolated as described in a, and after 12 days in vitro were exposed to 10 μM Aβ42 oligomers or vehicle. After 22 h of Aβ42 treatment, the fluorescent microtubule probe Tubulin Tracker was added to a final concentration of 250 nM for 30 min. Unfixed, live neurons were then imaged at ×20 using a Nikon Eclipse TS100 microscope with NIS Elements software. Note that Aβ42-induced neurite beading visualized by Tubulin Tracker appears very similar to that observed with βIII-tubulin immunostaining in a, and occurs more rapidly with higher Aβ42 concentration. Taken together, these results strongly suggest that Aβ42 disrupts the organization of microtubules in neurons. Scale bars in all frames 50 μmCC BY · PubMed Central
Fig. 2 Microtubule disruption in primary neurons is an early response to oligomeric Aβ42. Primary cortical neurons were cultured as in Fig. 1, and after 12 days in vitro, were labeled for 30 min with 250 nM Tubulin Tracker, rinsed, and then exposed to 10 μM Aβ42 oligomers or vehicle. Live imaging on an Andor spinning disk confocal microscope began 30 min after addition of Aβ42. a Fluorescence and differential interference contrast (DIC) images were acquired every 5 min for 3 h. Neurite beading, microtubule accumulation in varicosities (arrowheads), and microtubule fragmentation (arrows) in neurites were present 3.5 h after Aβ42 addition, in the absence of significant cell death or BACE1 elevation [49]. In contrast, the morphology of vehicle-treated neurons was unaffected, with the exception of a moderate decrease of fluorescence intensity. DIC imaging revealed that neurites of Aβ42-treated neurons were intact and continuous, even though they exhibited beading and microtubule fragmentation, indicating that the observed microtubule disruption was not the result of physical degeneration of neurites. Insets show higher magnification images of the boxed region of the Aβ42-treated culture to accentuate varicosity formation and microtubule fragmentation. b The ratios of Tubulin Tracker fluorescence intensity (Int.) at 3.5 h (hours) to that at 0.5 h after Aβ42 treatment were calculated for 46 image fields from two separate experiments and averaged for Aβ42-treated and vehicle-treated neurons. Overall Tubulin Tracker fluorescence intensity decreased in neurons over time due to photo-bleaching, as indicated by fluorescence intensity ratios below 1. Nevertheless, the Tubulin Tracker fluorescence intensity ratio for Aβ42-treated neurons showed a small but highly significant decrease compared to vehicle treatment (p = 0.004), suggesting microtubule depolymerization and reduced stability of microtubule networks after only 3.5 h of Aβ42 exposure. Error bars SEM; **, p < 0.01. c To investigate longer Aβ42 treatment times and minimize photo-bleaching, primary neuron cultures were prepared as above and images collected once every 60 min for 6 h. Neurite beading, aberrant microtubule localization, and microtubule fragmentation were even more prevalent and pronounced in neurons after 6.5 h compared to 3.5 h of Aβ42 treatment, while vehicle-treated neurites continued to appear normal. Scale bars 20 μm for all images in a, c
Fig. 2 Microtubule disruption in primary neurons is an early response to oligomeric Aβ42. Primary cortical neurons were cultured as in Fig. 1, and after 12 days in vitro, were labeled for 30 min with 250 nM Tubulin Tracker, rinsed, and then exposed to 10 μM Aβ42 oligomers or vehicle. Live imaging on an Andor spinning disk confocal microscope began 30 min after addition of Aβ42. a Fluorescence and differential interference contrast (DIC) images were acquired every 5 min for 3 h. Neurite beading, microtubule accumulation in varicosities (arrowheads), and microtubule fragmentation (arrows) in neurites were present 3.5 h after Aβ42 addition, in the absence of significant cell death or BACE1 elevation [49]. In contrast, the morphology of vehicle-treated neurons was unaffected, with the exception of a moderate decrease of fluorescence intensity. DIC imaging revealed that neurites of Aβ42-treated neurons were intact and continuous, even though they exhibited beading and microtubule fragmentation, indicating that the observed microtubule disruption was not the result of physical degeneration of neurites. Insets show higher magnification images of the boxed region of the Aβ42-treated culture to accentuate varicosity formation and microtubule fragmentation. b The ratios of Tubulin Tracker fluorescence intensity (Int.) at 3.5 h (hours) to that at 0.5 h after Aβ42 treatment were calculated for 46 image fields from two separate experiments and averaged for Aβ42-treated and vehicle-treated neurons. Overall Tubulin Tracker fluorescence intensity decreased in neurons over time due to photo-bleaching, as indicated by fluorescence intensity ratios below 1. Nevertheless, the Tubulin Tracker fluorescence intensity ratio for Aβ42-treated neurons showed a small but highly significant decrease compared to vehicle treatment (p = 0.004), suggesting microtubule depolymerization and reduced stability of microtubule networks after only 3.5 h of Aβ42 exposure. Error bars SEM; **, p < 0.01. c To investigate longer Aβ42 treatment times and minimize photo-bleaching, primary neuron cultures were prepared as above and images collected once every 60 min for 6 h. Neurite beading, aberrant microtubule localization, and microtubule fragmentation were even more prevalent and pronounced in neurons after 6.5 h compared to 3.5 h of Aβ42 treatment, while vehicle-treated neurites continued to appear normal. Scale bars 20 μm for all images in a, cCC BY · PubMed Central
Fig. 3 Tubulin isoforms are aberrantly localized in BACE1-positive peri-plaque dystrophic neurites in vivo. a Post-mortem brain sections of superior frontal gyrus from three AD patients and three cognitively normal controls were stained with antibodies against BACE1 (red) and βIII-tubulin (green), and methoxy XO4 (blue) to label amyloid deposits. Representative plaques from two cases (AD 14–190 and AD 11–193, Columns 1–2) are shown; additional examples in Fig. S2. Cognitively normal controls were negative for plaques, as expected (not shown). As previously reported [86], BACE1 immunostaining was observed in a halo of dystrophic neurites surrounding individual plaques. In contrast, βIII-tubulin immunostaining was almost entirely absent in peri-plaque BACE1-positive dystrophies. Non-dystrophic neuropil in areas adjacent to plaques exhibited normal intensities and patterns of βIII-tubulin immunostaining. Some red fluorescence (white arrows) represents non-specific background from blood vessels. Brain sections from the aggressive amyloid 5XFAD mouse model were stained with antibodies against BACE1 (red) and βIII-tubulin, acetylated α-tubulin or polyglutamylated tubulin (green). Representative 5XFAD amyloid deposits are shown (Columns 3–5), with plaque cores marked by asterisks; additional examples in Fig. S2. Similar to human AD, BACE1 accumulated in peri-plaque dystrophic neurites in 5XFAD brain sections. Additionally, the different tubulin isoforms were generally reduced in dystrophic halos around plaques, although tubulins often occurred in amorphous accumulations that showed little co-localization with BACE1 immunostaining. Scale bars in all frames 10 μm. b Immunofluorescence intensities of BACE1 and tubulin isoforms (as indicated at top of each column) in peri-plaque dystrophic neurites were measured and BACE1/tubulin intensity ratios calculated and compared to those in normal-appearing regions of neuropil within the same frame (Supplementary Methods). For human tissue, 16 dystrophies and corresponding non-dystrophic regions were measured per case. For murine tissue, BACE1/tubulin isoform ratios were determined for 11–20 BACE1-positive dystrophic regions and a corresponding number of nearby neuropil areas. BACE1/tubulin ratios for AD 14–190 and AD 11–193 (Panels 1 and 2, respectively) and 5XFAD mice (Panels 3–5) are shown. While there was substantial variation for dystrophic neurites, BACE1/tubulin intensity ratios for dystrophies were significantly elevated compared to those for normal neuropil for both AD cases and 5XFAD mice. Error bars SEM; ***p < 0.001. c The quantitative relationships between BACE1 and tubulin isoform immunofluorescence intensities by another method, intensity profiles as a function of distance across the plaque were generated (Supplementary Methods). Representative plaques are shown (upper row) for AD 14–190 and AD 11–193 (Panels 1 and 2, respectively) and 5XFAD mice (Panels 3–5). White line indicates path through plaque from which the intensity profiles were generated (bottom row). Note the inverse relationships between BACE1 and tubulin intensities as a function of distance across the plaque in each case. Taken together, these results suggest that tubulin, and hence microtubules, is reduced and/or mis-localized in peri-plaque dystrophic neurites. AU arbitrary units. Scale bars in all frames 10 μm
Fig. 3 Tubulin isoforms are aberrantly localized in BACE1-positive peri-plaque dystrophic neurites in vivo. a Post-mortem brain sections of superior frontal gyrus from three AD patients and three cognitively normal controls were stained with antibodies against BACE1 (red) and βIII-tubulin (green), and methoxy XO4 (blue) to label amyloid deposits. Representative plaques from two cases (AD 14–190 and AD 11–193, Columns 1–2) are shown; additional examples in Fig. S2. Cognitively normal controls were negative for plaques, as expected (not shown). As previously reported [86], BACE1 immunostaining was observed in a halo of dystrophic neurites surrounding individual plaques. In contrast, βIII-tubulin immunostaining was almost entirely absent in peri-plaque BACE1-positive dystrophies. Non-dystrophic neuropil in areas adjacent to plaques exhibited normal intensities and patterns of βIII-tubulin immunostaining. Some red fluorescence (white arrows) represents non-specific background from blood vessels. Brain sections from the aggressive amyloid 5XFAD mouse model were stained with antibodies against BACE1 (red) and βIII-tubulin, acetylated α-tubulin or polyglutamylated tubulin (green). Representative 5XFAD amyloid deposits are shown (Columns 3–5), with plaque cores marked by asterisks; additional examples in Fig. S2. Similar to human AD, BACE1 accumulated in peri-plaque dystrophic neurites in 5XFAD brain sections. Additionally, the different tubulin isoforms were generally reduced in dystrophic halos around plaques, although tubulins often occurred in amorphous accumulations that showed little co-localization with BACE1 immunostaining. Scale bars in all frames 10 μm. b Immunofluorescence intensities of BACE1 and tubulin isoforms (as indicated at top of each column) in peri-plaque dystrophic neurites were measured and BACE1/tubulin intensity ratios calculated and compared to those in normal-appearing regions of neuropil within the same frame (Supplementary Methods). For human tissue, 16 dystrophies and corresponding non-dystrophic regions were measured per case. For murine tissue, BACE1/tubulin isoform ratios were determined for 11–20 BACE1-positive dystrophic regions and a corresponding number of nearby neuropil areas. BACE1/tubulin ratios for AD 14–190 and AD 11–193 (Panels 1 and 2, respectively) and 5XFAD mice (Panels 3–5) are shown. While there was substantial variation for dystrophic neurites, BACE1/tubulin intensity ratios for dystrophies were significantly elevated compared to those for normal neuropil for both AD cases and 5XFAD mice. Error bars SEM; ***p < 0.001. c The quantitative relationships between BACE1 and tubulin isoform immunofluorescence intensities by another method, intensity profiles as a function of distance across the plaque were generated (Supplementary Methods). Representative plaques are shown (upper row) for AD 14–190 and AD 11–193 (Panels 1 and 2, respectively) and 5XFAD mice (Panels 3–5). White line indicates path through plaque from which the intensity profiles were generated (bottom row). Note the inverse relationships between BACE1 and tubulin intensities as a function of distance across the plaque in each case. Taken together, these results suggest that tubulin, and hence microtubules, is reduced and/or mis-localized in peri-plaque dystrophic neurites. AU arbitrary units. Scale bars in all frames 10 μmCC BY · PubMed Central
Fig. 4 Microtubules are strikingly absent in peri-plaque dystrophic axons. 5XFAD brain tissue was prepared for electron microscopy (EM) and assessed ultrastructurally for the presence of microtubules in peri-plaque dystrophic axons. a As previously reported [25], electron microscopy of 5XFAD brain revealed amyloid plaques (p) surrounded by dystrophic neurites (representative examples outlined in blue) filled with electron-dense multi-lamellar vesicles, possibly autophagic intermediates. b EM of a transverse section through a pair of dystrophic myelinated axons filled with multi-lamellar vesicles. Note that the lower portion of the axon on the left has lost its myelin sheath. c–f EM of serial ultrathin sections occasionally revealed series of longitudinal sections through dystrophic axons near amyloid plaques. Shown is such a series of a peri-plaque dystrophic myelinated axon with a portion of normal axon appearing on the left side of the dystrophy. Intact, continuous microtubules (yellow shading) are present in the morphologically normal part of the axon, but then microtubules become disorganized and mostly disappear within the dystrophic region. Note the dark outline of the surrounding myelin sheath, definitively confirming axonal identity. These ultrastructural images provide direct evidence that microtubules are disrupted and largely absent in peri-plaque dystrophic regions of axons. Images are spaced ~200 nm apart. f Higher magnification of rectangle in e. Scale bars 1 μm
Fig. 4 Microtubules are strikingly absent in peri-plaque dystrophic axons. 5XFAD brain tissue was prepared for electron microscopy (EM) and assessed ultrastructurally for the presence of microtubules in peri-plaque dystrophic axons. a As previously reported [25], electron microscopy of 5XFAD brain revealed amyloid plaques (p) surrounded by dystrophic neurites (representative examples outlined in blue) filled with electron-dense multi-lamellar vesicles, possibly autophagic intermediates. b EM of a transverse section through a pair of dystrophic myelinated axons filled with multi-lamellar vesicles. Note that the lower portion of the axon on the left has lost its myelin sheath. c–f EM of serial ultrathin sections occasionally revealed series of longitudinal sections through dystrophic axons near amyloid plaques. Shown is such a series of a peri-plaque dystrophic myelinated axon with a portion of normal axon appearing on the left side of the dystrophy. Intact, continuous microtubules (yellow shading) are present in the morphologically normal part of the axon, but then microtubules become disorganized and mostly disappear within the dystrophic region. Note the dark outline of the surrounding myelin sheath, definitively confirming axonal identity. These ultrastructural images provide direct evidence that microtubules are disrupted and largely absent in peri-plaque dystrophic regions of axons. Images are spaced ~200 nm apart. f Higher magnification of rectangle in e. Scale bars 1 μmCC BY · PubMed Central
Fig. 5 Microtubule motor proteins are aberrantly localized in BACE1-positive peri-plaque dystrophic neurites. Sections from 5XFAD mouse brains were stained with antibodies against BACE1 (red) and various components of the dynein–dynactin retrograde transport complex, dynein intermediate chain (green, a), p150glued (green, b), dynamitin (green, c), or the anterograde motor protein kinesin heavy chain (green, d). Representative amyloid deposits are shown; additional examples in Figs. S3 and S4. Dynein intermediate chain and p150glued were reduced in peri-plaque BACE1-positive dystrophic neurites, while dynamitin and kinesin heavy chain tended to accumulate in dystrophies and showed partial but limited co-localization with BACE1. These results together with evidence of microtubule disruption strongly suggest that axonal transport is impaired in dystrophic regions of peri-plaque axons. DAPI staining (blue) identified nuclei and autofluorescence of amyloid plaque cores (marked by asterisks). Scale bars 10 μm (a, b, d) and 20 μm (c)
Fig. 5 Microtubule motor proteins are aberrantly localized in BACE1-positive peri-plaque dystrophic neurites. Sections from 5XFAD mouse brains were stained with antibodies against BACE1 (red) and various components of the dynein–dynactin retrograde transport complex, dynein intermediate chain (green, a), p150glued (green, b), dynamitin (green, c), or the anterograde motor protein kinesin heavy chain (green, d). Representative amyloid deposits are shown; additional examples in Figs. S3 and S4. Dynein intermediate chain and p150glued were reduced in peri-plaque BACE1-positive dystrophic neurites, while dynamitin and kinesin heavy chain tended to accumulate in dystrophies and showed partial but limited co-localization with BACE1. These results together with evidence of microtubule disruption strongly suggest that axonal transport is impaired in dystrophic regions of peri-plaque axons. DAPI staining (blue) identified nuclei and autofluorescence of amyloid plaque cores (marked by asterisks). Scale bars 10 μm (a, b, d) and 20 μm (c)CC BY · PubMed Central
Fig. 6 BACE1-positive peri-plaque dystrophies accumulate the presynaptic protein synaptophysin and the lysosomal protease cathepsin D, but lack the active zone protein bassoon. Sections from 5XFAD mouse brains were stained with antibodies against BACE1 (red) and active zone protein bassoon (green, a), presynaptic protein synaptophysin (green, b), somatodendritic marker MAP2, (green, c), or lysosomal protease cathepsin D (green, d). Representative amyloid deposits are shown; additional examples in Figs. S3 and S4. Both bassoon and synaptophysin co-localized extensively with BACE1 in presynaptic terminals in the stratum lucidum (bottom row), but bassoon and synaptophysin were absent and enriched in peri-plaque dystrophies, respectively (top row). The somatodendritic protein MAP2, which did not co-localize with BACE1 in the stratum lucidum (bottom row), was absent in peri-plaque dystrophies (top row). The lysosomal protease cathepsin D was found in neuronal soma as expected and did not co-localize with BACE1 in stratum lucidum (bottom row). However, cathepsin D tended to accumulate in some dystrophies, indicating aberrant localization of lysosomes in peri-plaque dystrophic neurites. These results suggest that BACE1-positive peri-plaque dystrophies are largely presynaptic axons and terminals, although dystrophic terminals are unlikely to have active synapses as they lack bassoon. DAPI staining (blue) identified nuclei and autofluorescence of amyloid plaque cores (marked by asterisks). Scale bars 10 μm in all frames except for the bottom row, which is 20 μm
Fig. 6 BACE1-positive peri-plaque dystrophies accumulate the presynaptic protein synaptophysin and the lysosomal protease cathepsin D, but lack the active zone protein bassoon. Sections from 5XFAD mouse brains were stained with antibodies against BACE1 (red) and active zone protein bassoon (green, a), presynaptic protein synaptophysin (green, b), somatodendritic marker MAP2, (green, c), or lysosomal protease cathepsin D (green, d). Representative amyloid deposits are shown; additional examples in Figs. S3 and S4. Both bassoon and synaptophysin co-localized extensively with BACE1 in presynaptic terminals in the stratum lucidum (bottom row), but bassoon and synaptophysin were absent and enriched in peri-plaque dystrophies, respectively (top row). The somatodendritic protein MAP2, which did not co-localize with BACE1 in the stratum lucidum (bottom row), was absent in peri-plaque dystrophies (top row). The lysosomal protease cathepsin D was found in neuronal soma as expected and did not co-localize with BACE1 in stratum lucidum (bottom row). However, cathepsin D tended to accumulate in some dystrophies, indicating aberrant localization of lysosomes in peri-plaque dystrophic neurites. These results suggest that BACE1-positive peri-plaque dystrophies are largely presynaptic axons and terminals, although dystrophic terminals are unlikely to have active synapses as they lack bassoon. DAPI staining (blue) identified nuclei and autofluorescence of amyloid plaque cores (marked by asterisks). Scale bars 10 μm in all frames except for the bottom row, which is 20 μmCC BY · PubMed Central
Fig. 7 Levels of immature pro-cathepsin D are increased in 5XFAD mouse brain. a Cortices from 6-month 5XFAD (+) or non-transgenic (−) mice were homogenized and subjected to immunoblot analysis using antibodies against human APP (top panel; antibody 6E10) and the C-terminus of the lysosomal protease cathepsin D (CatD), which recognizes both immature (inactive) pro-CatD and mature (active) CatD heavy chain (middle panel). Ponceau S staining of the immunoblot was used to control for protein loading (bottom panel). Note that 43-kDa immature pro-CatD bands are more intense than 28 kDa mature CatD heavy chain bands, especially in 5XFAD cortices. b Band intensities from the immunoblot in a were quantified and normalized to total protein as determined by ponceau S staining intensity in respective lanes and then displayed as percentage of non-transgenic (non-Tg) control. Note that 5XFAD cortex levels of pro-CatD were nearly twofold higher than those in non-Tg cortex, while levels of CatD heavy chain were not significantly changed, suggesting that lysosomal maturation is impaired in 5XFAD brains. Error bars SEM; **p < 0.01; NS not significant
Fig. 7 Levels of immature pro-cathepsin D are increased in 5XFAD mouse brain. a Cortices from 6-month 5XFAD (+) or non-transgenic (−) mice were homogenized and subjected to immunoblot analysis using antibodies against human APP (top panel; antibody 6E10) and the C-terminus of the lysosomal protease cathepsin D (CatD), which recognizes both immature (inactive) pro-CatD and mature (active) CatD heavy chain (middle panel). Ponceau S staining of the immunoblot was used to control for protein loading (bottom panel). Note that 43-kDa immature pro-CatD bands are more intense than 28 kDa mature CatD heavy chain bands, especially in 5XFAD cortices. b Band intensities from the immunoblot in a were quantified and normalized to total protein as determined by ponceau S staining intensity in respective lanes and then displayed as percentage of non-transgenic (non-Tg) control. Note that 5XFAD cortex levels of pro-CatD were nearly twofold higher than those in non-Tg cortex, while levels of CatD heavy chain were not significantly changed, suggesting that lysosomal maturation is impaired in 5XFAD brains. Error bars SEM; **p < 0.01; NS not significantCC BY · PubMed Central
Fig. 8 Neoepitope antibodies recognize BACE1-cleaved APP and Aβ but not full-length APP in vivo. Sagittal brain sections of 5XFAD;BACE1+/+ and 5XFAD;BACE1−/− mice were immunostained with neoepitope antibodies to a the free C-terminus of BACE1-cleaved APP ectodomain ending in the Swedish mutation, sAPPβ (antibody ANJJ [45, 46], green), b the free N-terminus of BACE1-cleaved Aβ (antibody 3D6 [23], red), or c the free C-terminus of γ-secretase-cleaved Aβ42 (green). Sections were also co-immunostained with an antibody recognizing full-length APP (antibody Karen [64], red), then imaged by confocal microscopy. All three neoepitope immunoreactivities were present in soma (arrows), and processes in the case of sAPPβ (arrowheads), of pyramidal neurons in the cortex of 5XFAD;BACE1+/+ mice, while none were detected in 5XFAD;BACE1−/− cortex, despite overexpression of transgenic APP in pyramidal neurons of both genotypes. These data confirm that ANJJ, 3D6, and Aβ42 antibodies are selective for their respective neoepitopes and do not cross-react to full-length APP. DAPI staining (blue) identified nuclei and autofluorescence of amyloid deposit cores (marked by asterisks). Note that amyloid deposits are completely lacking in 5XFAD;BACE1−/− cortex, as previously reported [41]. Scale bars 10 μm (b), 20 μm (a)
Fig. 8 Neoepitope antibodies recognize BACE1-cleaved APP and Aβ but not full-length APP in vivo. Sagittal brain sections of 5XFAD;BACE1+/+ and 5XFAD;BACE1−/− mice were immunostained with neoepitope antibodies to a the free C-terminus of BACE1-cleaved APP ectodomain ending in the Swedish mutation, sAPPβ (antibody ANJJ [45, 46], green), b the free N-terminus of BACE1-cleaved Aβ (antibody 3D6 [23], red), or c the free C-terminus of γ-secretase-cleaved Aβ42 (green). Sections were also co-immunostained with an antibody recognizing full-length APP (antibody Karen [64], red), then imaged by confocal microscopy. All three neoepitope immunoreactivities were present in soma (arrows), and processes in the case of sAPPβ (arrowheads), of pyramidal neurons in the cortex of 5XFAD;BACE1+/+ mice, while none were detected in 5XFAD;BACE1−/− cortex, despite overexpression of transgenic APP in pyramidal neurons of both genotypes. These data confirm that ANJJ, 3D6, and Aβ42 antibodies are selective for their respective neoepitopes and do not cross-react to full-length APP. DAPI staining (blue) identified nuclei and autofluorescence of amyloid deposit cores (marked by asterisks). Note that amyloid deposits are completely lacking in 5XFAD;BACE1−/− cortex, as previously reported [41]. Scale bars 10 μm (b), 20 μm (a)CC BY · PubMed Central
Fig. 9 BACE1 accumulation in peri-plaque dystrophic neurites increases BACE1 cleavage of APP and generation of Aβ42. Sagittal brain sections of 5XFAD mice were co-immunostained with antibodies recognizing BACE1 and cleaved APP fragment neoepitopes (sAPPβ, 3D6, Aβ42) validated in Fig. 8. a The BACE1-cleaved free C-terminal neoepitope of sAPPβ (ANJJ, green) showed robust co-localization with elevated BACE1 (red) in peri-plaque dystrophic neurites. Note the intense sAPPβ immunoreactivity in dystrophies, while little if any sAPPβ signal is present in surrounding neuropil, demonstrating dramatically elevated BACE1 cleavage of APP in BACE1-positive dystrophic neurites near amyloid deposits. b Antibody 3D6 (green), which recognizes the free N-terminal neoepitope of BACE1-cleaved Aβ, also co-localized with elevated BACE1 (red) in dystrophic neurites, confirming increased BACE1 activity and Aβ generation in dystrophies. Antibody 3D6 also detects amyloid plaques, as expected (example marked with asterisk). c Like 3D6, an antibody recognizing the free C-terminal neoepitope generated after γ-secretase cleavage of Aβ42 (green) co-localized with elevated BACE1 (red) in peri-plaque dystrophies, and detected amyloid deposits, as expected (asterisk). d Co-immunostaining also demonstrated that both sAPPβ (green) and 3D6 (Aβ, red) neoepitopes co-localized in peri-plaque dystrophies. e Co-immunostaining with antibodies against BACE1 (red) and APP (Karen, green) also showed a high level of co-localization. Note that all cleaved APP fragment neoepitopes and BACE1 show a punctate immunostaining pattern in dystrophies, suggesting that they are localized to vesicles such as endosomes, while APP immunostaining appears more uniform, implying greater cell surface localization. Panels in the right column of each set are high-magnification images of the boxed regions in the frames of the left column. DAPI staining (blue) identified nuclei and autofluorescence of amyloid deposit cores (marked by asterisks). Scale bar sizes are indicated in bottom panels for images in each column
Fig. 9 BACE1 accumulation in peri-plaque dystrophic neurites increases BACE1 cleavage of APP and generation of Aβ42. Sagittal brain sections of 5XFAD mice were co-immunostained with antibodies recognizing BACE1 and cleaved APP fragment neoepitopes (sAPPβ, 3D6, Aβ42) validated in Fig. 8. a The BACE1-cleaved free C-terminal neoepitope of sAPPβ (ANJJ, green) showed robust co-localization with elevated BACE1 (red) in peri-plaque dystrophic neurites. Note the intense sAPPβ immunoreactivity in dystrophies, while little if any sAPPβ signal is present in surrounding neuropil, demonstrating dramatically elevated BACE1 cleavage of APP in BACE1-positive dystrophic neurites near amyloid deposits. b Antibody 3D6 (green), which recognizes the free N-terminal neoepitope of BACE1-cleaved Aβ, also co-localized with elevated BACE1 (red) in dystrophic neurites, confirming increased BACE1 activity and Aβ generation in dystrophies. Antibody 3D6 also detects amyloid plaques, as expected (example marked with asterisk). c Like 3D6, an antibody recognizing the free C-terminal neoepitope generated after γ-secretase cleavage of Aβ42 (green) co-localized with elevated BACE1 (red) in peri-plaque dystrophies, and detected amyloid deposits, as expected (asterisk). d Co-immunostaining also demonstrated that both sAPPβ (green) and 3D6 (Aβ, red) neoepitopes co-localized in peri-plaque dystrophies. e Co-immunostaining with antibodies against BACE1 (red) and APP (Karen, green) also showed a high level of co-localization. Note that all cleaved APP fragment neoepitopes and BACE1 show a punctate immunostaining pattern in dystrophies, suggesting that they are localized to vesicles such as endosomes, while APP immunostaining appears more uniform, implying greater cell surface localization. Panels in the right column of each set are high-magnification images of the boxed regions in the frames of the left column. DAPI staining (blue) identified nuclei and autofluorescence of amyloid deposit cores (marked by asterisks). Scale bar sizes are indicated in bottom panels for images in each columnCC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 44 Not checked · 138 Own results and interpretations

99 more claims

Create a free account to see all 182 claims and to verify the 76 references still open.

See all claims — free account
  • It may state two separate claims as one. 61
  • Probably not a substantial claim. 27
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 93 references

Cited by

See all 338

Metadata

Authors
Sadleir, K. R., Kandalepas, P. C., Buggia-Prévot, V., Nicholson, D. A., Thinakaran, G., & Vassar, R.
Affiliations
  • Northwestern University (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • Rush University (US)
  • University of Chicago (US)
Corresponding author
Vassar, Robert
Venue
Acta Neuropathologica
Published
2016-03-18
Volume
132
Issue
2
Pages
235-256
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2297442499
Cited by
294
References
91
Citations by year
2026: 25 · 2025: 30 · 2024: 31 · 2023: 54 · 2022: 34 · 2021: 26 · 2020: 30 · 2019: 22 · 2018: 20 · 2017: 16 · 2016: 4
FWCI
16.62
Type
journal article
Language
en
Open access
Licence
Locations
  • Acta Neuropathologica (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Center for Strategic Scientific Initiatives, National Cancer Institute (P30 CA060553)
  • National Center for Research Resources (1S10 RR031680-01)
  • National Institutes of Health (1S10OD010398-01, T32-070715)
  • National Institute on Aging (R01 AG030142, R01 AG019070, R01 AG13854)
  • Cure Alzheimer's Fund (N/A)
  • The Baila Foundation (N/A)
  • BrightFocus Foundation
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
Alzheimer's disease, amyloid plaques, microtubule disruption, BACE1, amyloid-beta, Aβ42 oligomers, axonal transport, autophagy, kinesin, dynein, lysosomal dysfunction, cathepsin D, APP cleavage, 5xFAD mice
MeSH terms
Alzheimer Disease, Animals, Axons, Disease Models, Animal, Mice, Inbred C57BL, Mice, Transgenic, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Neurites, Amyloid beta-Protein Precursor, Presynaptic Terminals, Amyloid Precursor Protein Secretases, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease. https://app.cochat.ai/papers/10.1007/s00401-016-1558-9
The paper
Sadleir, K. R., Kandalepas, P. C., Buggia-Prévot, V., Nicholson, D. A., Thinakaran, G., & Vassar, R. (2016). Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease. Acta Neuropathologica. https://doi.org/10.1007/s00401-016-1558-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.